Skip to main content

Find Clinical Trials

Home
Conditions
Kernicterus

Clinical trial condition

Kernicterus

Explore clinical trials studying Kernicterus. Study availability and eligibility vary by location and protocol.

6 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Kernicterus trial results

Not Yet Recruiting

Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns

NCT07315126

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +16 more
Locations: Maternité Port Royal Paris, France

View Trial Details

Completed

Bilistick Point-of-care System 2.0 Bilirubin Validation

NCT06058910

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +18 more
Locations: Kettering Health Main Campus Kettering, Ohio, United States

View Trial Details

Completed

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

NCT02691156

Conditions: Bilirubin-induced Neurologic Dysfunction, Brain Diseases, Brain Diseases, Metabolic, +22 more
Locations: Lucile-Packard Children's Hospital at Stanford Stanford, California, United States

View Trial Details

Completed

Efficacy and Safety of Stannsoporfin in Neonates

NCT02685137

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +15 more
Locations: Pennsylvania Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries

NCT01754688

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +14 more
Locations: Massey Street Children's Hospital Lagos, Nigeria

View Trial Details

Active, Not Recruiting

Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration

NCT04584983

Conditions: Bilirubin Encephalopathy, Brain Diseases, Brain Diseases, Metabolic, +20 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details